Diabetes is one of the most common chronic diseases globally, having a significant impact on the quality of life of patients and on the health system. Complications associated with diabetes, including microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular disease, stroke), can be devastating if not prevented and managed in time.
Platform Diabeta supports doctors by providing the necessary tools to identify, prevent and treat complications of diabetes through quick access to relevant information from SPCs, up-to-date guides and treatment protocols.
How does Diabetes contribute to the prevention of complications?
Quick access to relevant information from SPCs
SPCs are an essential resource for doctors who prescribe antidiabetic treatments. Through Diabeta, doctors can quickly access information on therapeutic indications, contraindications, drug interactions and recommended doses. E.g:
- Choosing an SGLT2 inhibitor for patients with diabetes and kidney failure may reduce the risk of progression of kidney disease.
- Recommendations for the use of GLP-1 agonists to reduce cardiovascular risk are clearly detailed and easy to consult.
Screening and prevention guides and protocols
Diabeta incorporates the latest clinical guidelines (ADA, SRDNBM, ESC) which include specific recommendations for the prevention of complications. Your doctor can quickly find:
- Screening protocols for diabetic retinopathy – including the frequency of eye checks.
- Prevention strategies for the diabetic foot, including patient education and regular inspection of the legs.
Tools for making quick clinical decisions
The platform includes clinical computers and interactive algorithms that help doctors customize treatment and intervene early. examples:
- Information for adjusting basal and prandial insulin doses to avoid hypoglycaemia.
- Cardiovascular risk assessment through integrated scores.
Preventing and managing complications of diabetes requires a proactive approach, and Diabeta it is an indispensable tool for doctors who want to constantly provide quality care to their patients. With access to detailed SPCs, up-to-date guides and clear protocols, Diabeta supports informed decision-making, helping to reduce the burden of complications of diabetes and improve the quality of life of patients.
Diabeta was developed by a Romanian company, Apollo Technologies, specialized in creating professional applications based on artificial intelligence. The application is made available to doctors in professional medical communities administered by People and Companies, with the support of the partners Novo Nordisk, Boehringer Ingelheim and Medtronic.
